US 10081624
Heterocyclic compound
granted A61KA61K31/4245A61K31/454
Quick answer
US patent 10081624 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/4245, A61K31/454, A61K31/4709, A61K31/4725